OrbiMed Advisors as of Dec. 31, 2012
Portfolio Holdings for OrbiMed Advisors
OrbiMed Advisors holds 104 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 6.9 | $224M | 8.9M | 25.08 | |
| Merck & Co (MRK) | 3.7 | $120M | 2.9M | 40.94 | |
| Infinity Pharmaceuticals (INFIQ) | 3.6 | $118M | 3.4M | 35.00 | |
| Biogen Idec (BIIB) | 3.6 | $116M | 790k | 146.37 | |
| Express Scripts Holding | 3.5 | $114M | 2.1M | 54.00 | |
| Onyx Pharmaceuticals | 3.3 | $107M | 1.4M | 75.53 | |
| Illumina (ILMN) | 3.0 | $98M | 1.8M | 55.59 | |
| Life Technologies | 2.9 | $93M | 1.9M | 49.03 | |
| Abbott Laboratories (ABT) | 2.9 | $93M | 3.0M | 31.34 | |
| Gilead Sciences (GILD) | 2.7 | $89M | 2.4M | 36.72 | |
| Mylan | 2.6 | $83M | 3.0M | 27.45 | |
| Hca Holdings (HCA) | 2.5 | $80M | 2.6M | 30.17 | |
| Intercept Pharmaceuticals In | 2.3 | $74M | 2.2M | 34.24 | |
| Medivation | 2.2 | $73M | 1.4M | 51.16 | |
| Amgen (AMGN) | 2.2 | $72M | 833k | 86.20 | |
| UnitedHealth (UNH) | 2.1 | $67M | 1.2M | 54.24 | |
| Incyte Corporation (INCY) | 2.0 | $66M | 4.0M | 16.61 | |
| Celgene Corporation | 2.0 | $65M | 824k | 78.47 | |
| Bristol Myers Squibb (BMY) | 2.0 | $64M | 2.0M | 32.59 | |
| Thermo Fisher Scientific (TMO) | 2.0 | $64M | 998k | 63.78 | |
| WellPoint | 1.7 | $55M | 896k | 60.92 | |
| Warner Chilcott Plc - | 1.6 | $50M | 4.2M | 12.04 | |
| BioMarin Pharmaceutical (BMRN) | 1.5 | $50M | 1.0M | 49.20 | |
| Affymax (AFFY) | 1.5 | $49M | 2.6M | 18.99 | |
| EXACT Sciences Corporation (EXAS) | 1.4 | $46M | 4.4M | 10.59 | |
| Allergan | 1.4 | $45M | 489k | 91.73 | |
| Impax Laboratories | 1.4 | $44M | 2.2M | 20.49 | |
| MAP Pharmaceuticals | 1.4 | $44M | 2.8M | 15.65 | |
| Humana (HUM) | 1.2 | $40M | 581k | 68.63 | |
| OraSure Technologies (OSUR) | 1.2 | $39M | 5.4M | 7.18 | |
| Regeneron Pharmaceuticals (REGN) | 1.2 | $38M | 220k | 171.07 | |
| Baxter International (BAX) | 1.1 | $35M | 524k | 66.66 | |
| Zimmer Holdings (ZBH) | 1.1 | $35M | 517k | 66.66 | |
| NxStage Medical | 1.1 | $34M | 3.1M | 11.25 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $33M | 4.4M | 7.48 | |
| Johnson & Johnson (JNJ) | 1.0 | $32M | 451k | 70.10 | |
| Sequenom | 1.0 | $32M | 6.7M | 4.71 | |
| Antares Pharma | 0.9 | $30M | 7.9M | 3.81 | |
| 3SBio (SSRX) | 0.9 | $29M | 2.1M | 13.64 | |
| Pacira Pharmaceuticals (PCRX) | 0.9 | $28M | 1.6M | 17.47 | |
| Alexion Pharmaceuticals | 0.8 | $25M | 264k | 93.74 | |
| Supernus Pharmaceuticals (SUPN) | 0.7 | $24M | 3.3M | 7.17 | |
| Affymetrix | 0.7 | $22M | 6.8M | 3.17 | |
| Spdr S&p 500 Etf (SPY) | 0.7 | $21M | 150k | 142.41 | |
| CIGNA Corporation | 0.6 | $21M | 388k | 53.46 | |
| Aetna | 0.6 | $20M | 426k | 46.31 | |
| Pernix Therapeutics Holdings | 0.6 | $20M | 2.5M | 7.75 | |
| D Fluidigm Corp Del (LAB) | 0.6 | $20M | 1.4M | 14.31 | |
| Dendreon Corporation | 0.6 | $18M | 3.4M | 5.29 | |
| XenoPort | 0.6 | $18M | 2.3M | 7.77 | |
| Natus Medical | 0.5 | $18M | 1.6M | 11.16 | |
| Incyte Corp note 4.750%10/0 | 0.5 | $17M | 8.7M | 2.00 | |
| Array BioPharma | 0.5 | $16M | 4.3M | 3.72 | |
| Puma Biotechnology (PBYI) | 0.5 | $16M | 850k | 18.75 | |
| MAKO Surgical | 0.5 | $15M | 1.2M | 12.85 | |
| Given Imaging | 0.5 | $15M | 855k | 17.47 | |
| Salix Pharmaceuticals | 0.4 | $13M | 331k | 40.47 | |
| Perrigo Company | 0.4 | $12M | 118k | 104.03 | |
| Vivus | 0.4 | $12M | 921k | 13.42 | |
| Hi-Tech Pharmacal | 0.4 | $12M | 333k | 34.98 | |
| NPS Pharmaceuticals | 0.4 | $12M | 1.3M | 9.10 | |
| Repros Therapeutics | 0.3 | $9.3M | 591k | 15.75 | |
| Vocera Communications | 0.3 | $9.4M | 375k | 25.10 | |
| Acorda Therapeutics | 0.3 | $8.9M | 359k | 24.86 | |
| WellCare Health Plans | 0.3 | $8.9M | 182k | 48.69 | |
| Endocyte | 0.3 | $8.6M | 958k | 8.98 | |
| Valeant Pharmaceuticals Int | 0.2 | $8.2M | 138k | 59.77 | |
| Cardinal Health (CAH) | 0.2 | $7.8M | 189k | 41.18 | |
| Medtronic | 0.2 | $7.9M | 192k | 41.02 | |
| Centene Corporation (CNC) | 0.2 | $7.7M | 188k | 41.00 | |
| McKesson Corporation (MCK) | 0.2 | $7.4M | 76k | 96.96 | |
| DaVita (DVA) | 0.2 | $7.2M | 65k | 110.52 | |
| Agilent Technologies Inc C ommon (A) | 0.2 | $6.4M | 157k | 40.94 | |
| Stryker Corporation (SYK) | 0.2 | $6.3M | 115k | 54.82 | |
| Cubist Pharmaceuticals | 0.2 | $6.1M | 144k | 42.05 | |
| Uroplasty | 0.2 | $5.7M | 1.8M | 3.25 | |
| XOMA CORP Common equity shares | 0.2 | $5.8M | 2.4M | 2.40 | |
| St. Jude Medical | 0.2 | $5.2M | 145k | 36.14 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $5.2M | 1.1M | 4.65 | |
| Hologic (HOLX) | 0.1 | $5.0M | 250k | 20.01 | |
| Amarin Corporation | 0.1 | $4.9M | 600k | 8.09 | |
| Dendreon Corp note | 0.1 | $4.9M | 6.5M | 0.76 | |
| Edwards Lifesciences (EW) | 0.1 | $4.5M | 50k | 90.18 | |
| CareFusion Corporation | 0.1 | $4.4M | 155k | 28.58 | |
| Molina Healthcare (MOH) | 0.1 | $4.6M | 171k | 27.06 | |
| Cell Therapeutics | 0.1 | $4.6M | 3.6M | 1.30 | |
| Forest Laboratories | 0.1 | $4.2M | 120k | 35.32 | |
| Achillion Pharmaceuticals | 0.1 | $4.2M | 519k | 8.01 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.1 | $3.6M | 87k | 41.90 | |
| Boston Scientific Corporation (BSX) | 0.1 | $3.7M | 650k | 5.73 | |
| Derma Sciences | 0.1 | $3.6M | 325k | 11.11 | |
| CUBIST PHARM CONVERTIBLE security | 0.1 | $3.1M | 2.0M | 1.56 | |
| Biodel | 0.1 | $3.3M | 1.4M | 2.35 | |
| GROUP Affymetrix Inc cnv | 0.1 | $3.4M | 4.1M | 0.83 | |
| Syneron Medical Ltd ord | 0.1 | $3.0M | 350k | 8.67 | |
| Covance | 0.1 | $2.8M | 48k | 57.77 | |
| Volcano Corporation note 1.750%12/0 | 0.1 | $3.0M | 3.0M | 1.01 | |
| Newlink Genetics Corporation | 0.1 | $2.5M | 200k | 12.50 | |
| Curis | 0.1 | $1.6M | 469k | 3.43 | |
| Celsion Corporation | 0.1 | $1.6M | 200k | 8.19 | |
| Solta Medical | 0.0 | $1.2M | 457k | 2.67 | |
| Auxilium Pharmaceuticals | 0.0 | $1.1M | 60k | 18.53 | |
| Sinovac Biotech | 0.0 | $716k | 228k | 3.14 | |
| Celgene Corp right 12/31/2011 | 0.0 | $315k | 49k | 6.42 |
